AlzChem Group Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de AlzChem Group de 12.6% y 3.8% por año respectivamente. Se prevé que el BPA crezca en un 12.6% al año. Se espera que la rentabilidad financiera sea de 20.3% en 3 años.
Información clave
10.7%
Tasa de crecimiento de los beneficios
10.8%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Chemicals | 38.8% |
Tasa de crecimiento de los ingresos | 4.3% |
Rentabilidad financiera futura | 21.0% |
Cobertura de analistas | Low |
Última actualización | 15 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising
May 08Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being
May 01AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 26Is AlzChem Group (ETR:ACT) A Risky Investment?
Apr 11AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20
Mar 29The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More
Mar 07Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching
Nov 01Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?
Oct 12AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
May 06AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment
May 05AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05
Apr 05AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05
Mar 04AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year
Apr 24AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00
Mar 29AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00
Feb 27AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 23Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?
Jun 10At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?
Apr 07AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?
Mar 23AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price
Mar 10Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 24Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)
Feb 11Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year
Aug 07Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?
Jul 20Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?
Jul 03Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 623 | 52 | 35 | 76 | 4 |
12/31/2025 | 591 | 46 | 24 | 66 | 4 |
12/31/2024 | 563 | 41 | 30 | 67 | 4 |
3/31/2024 | 543 | 39 | 75 | 96 | N/A |
12/31/2023 | 546 | 35 | 52 | 73 | N/A |
9/30/2023 | 538 | 30 | 30 | 55 | N/A |
6/30/2023 | 559 | 28 | 28 | 53 | N/A |
3/31/2023 | 574 | 30 | -10 | 12 | N/A |
12/31/2022 | 550 | 30 | -33 | -4 | N/A |
9/30/2022 | 534 | 29 | -25 | 4 | N/A |
6/30/2022 | 487 | 28 | -28 | 0 | N/A |
3/31/2022 | 454 | 27 | 3 | 29 | N/A |
12/31/2021 | 429 | 28 | 14 | 43 | N/A |
9/30/2021 | 420 | 27 | 11 | 40 | N/A |
6/30/2021 | 406 | 26 | 34 | 63 | N/A |
3/31/2021 | 397 | 23 | 14 | 48 | N/A |
12/31/2020 | 386 | 20 | 20 | 49 | N/A |
9/30/2020 | 370 | 16 | 10 | 52 | N/A |
6/30/2020 | 389 | 17 | 11 | 53 | N/A |
3/31/2020 | 387 | 17 | 20 | 54 | N/A |
12/31/2019 | 385 | 18 | 2 | 44 | N/A |
9/30/2019 | 389 | 19 | 2 | 42 | N/A |
6/30/2019 | 380 | 18 | -18 | 22 | N/A |
3/31/2019 | 380 | 20 | -20 | 33 | N/A |
12/31/2018 | 383 | 23 | -5 | 35 | N/A |
9/30/2018 | 380 | 22 | 12 | 24 | N/A |
6/30/2018 | 398 | 32 | -1 | 31 | N/A |
3/31/2018 | 364 | 21 | 2 | 23 | N/A |
12/31/2017 | 361 | 20 | N/A | 31 | N/A |
9/30/2017 | 356 | 22 | N/A | 31 | N/A |
12/31/2016 | 333 | 15 | N/A | 33 | N/A |
9/30/2016 | 331 | 12 | N/A | 39 | N/A |
12/31/2015 | 329 | 15 | N/A | 30 | N/A |
12/31/2014 | 298 | 14 | N/A | 18 | N/A |
12/31/2013 | 302 | 17 | N/A | 16 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (12.6% al año) de ACT es superior a la tasa de ahorro (0.6%).
Beneficios vs. Mercado: Se prevé que los beneficios (12.6% al año) de ACT crezcan menos que el mercado German (14.8% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de ACT crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (3.8% al año) de ACT crezcan más despacio que el mercado de German (5.4% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 3.8% al año) de ACT crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de ACT sea alta dentro de 3 años (20.3%)